Stay updated with breaking news from Cve Dmt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Small Pharma Inc. (CVE:DMT – Get Rating) reached a new 52-week low during trading on Monday . The stock traded as low as C$0.21 and last traded at C$0.21, with a volume of 203932 shares changing hands. The stock had previously closed at C$0.24. Separately, Eight Capital set a C$1.00 price target on shares of […]
Small Pharma’s (CVE:DMT) Carol Routledge, Chief Medical and Scientific Officer joins Proactive London’s Katie Pilbeam to discuss their specialism in...
Small Pharma on conducting world’s first clinical trials for psychedelic DMT and listing in Canada Small Pharma's (CVE:DMT) Peter Rands joins Proactive to introduce his company after launching on Toronto’s TSX Venture Exchange, raising C$58mln to develop medicines based on N,N-Dimethyltryptamine (DMT) to treat depression. The firm is committed to helping accelerate the development of effective therapeutic treatments for mental health disorders. The company is currently conducting the world’s first clinical trials exploring the potential for the psychedelic N, N-Dimethyltryptamine (DMT) ...